Population pharmacokinetics and pharmacodynamics of pyronaridine
Pyronaridine/Artesunate (PA) 3:1 fixed dose combination is a novel artemisinin-based combination therapy (ACT) in development for the treatment of acute uncomplicated Plasmodium falciparum or Plasmodium vivax malaria. An understanding of both pharmacokinetics and...
Main Author: | |
---|---|
Other Authors: | |
Format: | Others |
Language: | English |
Published: |
University of Iowa
2013
|
Subjects: | |
Online Access: | https://ir.uiowa.edu/etd/4876 https://ir.uiowa.edu/cgi/viewcontent.cgi?article=4917&context=etd |